Master Genetics
for USMLE Step 1
Access 30+ high-yield questions tailored for the 2026 syllabus. Includes AI-powered explanations and performance tracking.
Core Concepts
Core genetics for USMLE Step 1 covers molecular processes, inheritance patterns, chromosomal disorders, and population genetics. Focus on high-yield examples and diagnostic principles.
- Molecular Basics:
- DNA/RNA: Replication, Transcription, Translation. Key enzymes: DNA/RNA pol, helicase, ligase.
- Mutations: Point (silent, missense, nonsense), Frameshift (indel not mult of 3), Splice site.
- Trinucleotide Repeats: Expansion causes anticipation. Ex: Huntington (CAG), Myotonic Dystrophy (CTG), Fragile X (CGG), Friedreich Ataxia (GAA).
- Mendelian Inheritance:
- Autosomal Dominant (AD): Vertical transmission, 50% risk, male-to-male. Ex: Huntington, Marfan, Neurofibromatosis 1.
- Autosomal Recessive (AR): Horizontal, 25% risk (carrier parents), skipped generations, consanguinity. Ex: Cystic Fibrosis, Sickle Cell, PKU.
- X-Linked Dominant (XD): No male-to-male. Fathers to all daughters. Ex: Fragile X (some presentations), Rett.
- X-Linked Recessive (XR): No male-to-male. Sons of carrier mothers 50%. Males more affected. Ex: Hemophilia, Duchenne Muscular Dystrophy, G6PD deficiency.
- Mitochondrial: Maternal inheritance (all children), heteroplasmy. Ex: Leber hereditary optic neuropathy (LHON), MELAS.
- Non-Mendelian Inheritance:
- Genomic Imprinting: Gene expression based on parental origin (methylation). Ex: Prader-Willi (paternal deletion/maternal UPD), Angelman (maternal deletion/paternal UPD).
- Mosaicism: Presence of genetically distinct cell lines within an individual.
- Heterogeneity: Locus (different genes, same phenotype), Allelic (different mutations same gene, same phenotype).
- Chromosomal Abnormalities:
- Aneuploidy:
- Trisomy 21 (Down): ID, epicanthal folds, single palmar crease, cardiac defects.
- Trisomy 18 (Edwards): Severe ID, micrognathia, clenched hands.
- Trisomy 13 (Patau): Cleft lip/palate, polydactyly.
- Turner (45, XO): Short stature, webbed neck, coarctation of aorta, primary amenorrhea.
- Klinefelter (47, XXY): Tall stature, gynecomastia, small testes.
- Structural: Deletions (DiGeorge 22q11 deletion), Translocations (Robertsonian).
- Aneuploidy:
- Hardy-Weinberg Principle: p^2 + 2pq + q^2 = 1 (genotype freq); p + q = 1 (allele freq). Assumes: no mutation, no migration, no selection, random mating, large population.
Clinical Presentation
- Highly variable, often multisystemic.
- Developmental delay, intellectual disability, dysmorphic features.
- Specific organ dysfunction (e.g., cardiac, renal, neurological).
- Metabolic crises (inborn errors of metabolism), cancer predisposition. Family history is key.
Diagnosis (Gold Standard)
- Karyotyping: For gross chromosomal abnormalities (aneuploidy, large translocations).
- FISH (Fluorescence In Situ Hybridization): For targeted microdeletions/duplications (e.g., DiGeorge, Prader-Willi).
- Array CGH (Comparative Genomic Hybridization): Genome-wide detection of copy number variants (deletions/duplications).
- PCR-based Methods: For trinucleotide repeats, specific point mutations.
- Sanger Sequencing: Gold standard for specific gene sequencing (point mutations, small indels).
- Next-Generation Sequencing (NGS) (Exome/Genome): High-throughput for panels, exomes, or whole genomes, especially for heterogeneous or unknown causes.
- Biochemical Assays: For inborn errors of metabolism (enzyme activity, metabolite levels).
- Prenatal: Amniocentesis, Chorionic Villus Sampling (CVS), Non-Invasive Prenatal Screening (NIPS).
Management (First Line)
- Supportive Care: Symptom management, rehabilitation, nutritional adjustments (e.g., PKU diet).
- Enzyme Replacement Therapy (ERT): For specific lysosomal storage diseases (e.g., Gaucher disease).
- Pharmacological Interventions: Targeted therapies for specific molecular defects (e.g., CFTR modulators for Cystic Fibrosis).
- Genetic Counseling: Essential for risk assessment, family planning, and education.
- Surveillance: Regular monitoring for associated complications (e.g., cancer screening).
- Gene Therapy: Emerging field for specific conditions (e.g., Spinal Muscular Atrophy).
Exam Red Flags
- Quickly interpret pedigrees for AD, AR, XD, XR. Remember no male-to-male transmission for X-linked disorders.
- Distinguish Genomic Imprinting (parental origin-specific expression) from simple deletion or Uniparental Disomy. Prader-Willi is paternal, Angelman is maternal.
- Associate common chromosomal disorders (Down, Turner, Klinefelter, DiGeorge) with their classic clinical features and genetic basis.
- Anticipation in a pedigree always points to trinucleotide repeat expansion disorders (e.g., Huntington, Fragile X).
- Understand and apply Hardy-Weinberg equilibrium assumptions and calculations for allele/genotype frequencies.
- Match diagnostic tests (Karyotyping, FISH, Array CGH, Sanger, NGS) to the appropriate size and type of genetic abnormality they detect.
Sample Practice Questions
A rare autosomal recessive disorder has a birth prevalence of 1 in 2,500 live births in a specific population. Assuming the population is in Hardy-Weinberg equilibrium, and there is complete penetrance, what is the approximate frequency of carriers for this disorder in this population?
A 6-year-old boy is brought to the clinic by his mother due to progressive muscle weakness. She reports that he has difficulty climbing stairs, frequently falls, and uses his hands to push himself up from a squatting position (Gower's sign). His calves appear unusually large. Family history reveals a maternal uncle who had similar symptoms and died in his late teens. Physical examination confirms pseudohypertrophy of the calves and generalized hypotonia. Laboratory tests show significantly elevated creatine kinase levels. Which of the following is the most likely inheritance pattern for this condition?
A 4-year-old girl is diagnosed with cystic fibrosis after presenting with recurrent respiratory infections and steatorrhea. Genetic testing confirms homozygous F508del mutations. Her parents are concerned about the long-term management and potential complications. Beyond respiratory and nutritional support, which of the following is an essential long-term screening measure for this patient?
Ready to see the answers?
Unlock All AnswersUSMLE Step 1
- ✓ 30+ Genetics Questions
- ✓ AI Tutor Assistance
- ✓ Detailed Explanations
- ✓ Performance Analytics